Sains dan Kebijakan

Muh. Akbar Bahar

Foto Diri

Universitas Hasanuddin

Jabatan
  • Wakil Dekan Bidang Kemitraan, Riset, Inovasi, & Alumni

Dr. Muh. Akbar Bahar (1986) adalah Dosen Fakultas Farmasi, Universitas Hasanuddin, sejak tahun 2009. Saat ini, ia diberikan amanah sebagai Wakil Dekan Bidang Kerja Sama, Riset, Inovasi, dan Alumni Fakultas Farmasi Universitas Hasanuddin (2024-2028). Di tingkat nasional, ia merupakan Anggota Bidang Evaluasi dan Ujian Kolegium Farmasi Indonesia (2024–2028).  Dr. Bahar meraih gelar Doktor dari Research group of PharmacoTherapy, -Epidemiology, and -Economics (PTEE), University of Groningen (Belanda), Magister dari Applied Pharmacology Laboratory, University of Toyama (Jepang), serta menyelesaikan pendidikan Profesi Apoteker dan Sarjana Sains di Fakultas Farmasi, Universitas Hasanuddin. Ia juga pernah menjadi Visiting Scientist di Institute of Clinical Pharmacy, University of Szeged, Hungaria. Bidang riset utama yang digelutinya adalah farmakoepidemiologi dan farmakologi, dengan H-index Scopus 13 dan telah menghasilkan 47 publikasi terindeks Scopus. Saat ini, ia memimpin Pharmacoepidemiology Research Group (PharmaEpid-RG) dan masih menjabat sebagai Wakil Ketua Komisi Etik Penelitian Farmasi dan Kesehatan, Fakultas Farmasi, Universitas Hasanuddin. Ia juga menjadi editor di dua jurnal ilmiah dan mitra bestari pada lebih dari 40 jurnal nasional dan internasional


Publikasi Relevan
  • Ashan, D., Wahyudin, E., Csupor, D., & Bahar, M. A. (2025). Navigating complementary and alternative medicine use, medication adherence, and herb–drug interaction risks among gout patients: a multicenter cross-sectional study in indonesia. Journal of Complementary and Integrative Medicine.
  • Rauf, M., Djabir, Y. Y., Rahim, A., Tóth, B., & Bahar, M. A. (2025). Exploring the Use of Complementary and Alternative Medicine During Pregnancy: A Cross-Sectional Study from Indonesia. European Journal of Integrative Medicine, 102507.
  • Antong, R. A., Kusuma, I. Y., Manggau, M. A., & Bahar, M. A. (2025). The impact of drug-drug interactions between proton pump inhibitors and metformin: A systematic review of clinical evidence. Pharmacia, 72, 1-10.
  • Bahar, M. A., Kausar, M. N., Khairunnisa, K., & Pradipta, I. S. (2025). The incentivized drug information services among community pharmacists: a multi-centre cross-sectional study in Indonesia. Primary Health Care Research & Development, 26, e7.
  • Kusuma, I. Y., Benko, R., Bahar, M. A., Pitaloka, D. A. E., Soeharto, S., Nuari, D. A., ... & Matuz, M. (2025). Development and validation of a psychometric scale for assessing pharmacy students’ perceptions and attitudes toward antimicrobial resistance and antimicrobial stewardship in Indonesia: the PATARAS study. BMC Medical Education, 25(1), 805.
  • Kusuma, I. Y., Visnyovszki, Á., & Bahar, M. A. (2024). Mapping the Mpox discourse: A network and sentiment analysis. Exploratory Research in Clinical and Social Pharmacy, 16, 100521.
  • Jannah, R., Manggau, M. A., & Bahar, M. A. (2024). Association Between Irrational Prophylactic Antibiotic Use and Post-Surgical Infections in Caesarean Section Patients at Indonesian Regional Hospitals. Gaceta Médica de Caracas, 132(2).
  • Bahar, M. A., Kusuma, I. Y., Visnyovszki, Á., Matuz, M., Benkő, R., Ferenci, T., ... & Csupor, D. (2024). Favipiravir does not improve viral clearance in mild to moderate COVID-19–A systematic review and meta-analysis of randomized controlled trials. Heliyon, 10(9).
  • Kusuma, I. Y., Bahar, M. A., Nuari, D. A., Prabandari, R., Soeharto, S., Csupor, D., ... & Matuz, M. (2024). Antibiotic knowledge assessment questionnaire in undergraduate pharmacy students: A Rasch analysis of validity evidence. Pharmacy Education, 24(1), 54-78.
  • Érszegi, A., Csupor, D., Bodó, G., Engi, Z., Bahar, M. A., Matuz, M., ... & Viola, R. (2024). High rate of potentially inappropriate medication use in older people: a case–control study. GeroScience, 46(5), 5217-5233.
  • Kusuma, I. Y., Muddather, H. F., Kurnianto, A. A., Bahar, M. A., Kurniasih, K. I., Tololiu, K. E., ... & Benkő, R. (2024). Telepharmacy in Indonesia: Navigating knowledge, perception, and readiness among 6,000 pharmacists and related sociodemographic determinants. Telemedicine and e-Health, 30(9), 2483-2494.
  • Kusuma, I. Y., Habibie, H., Bahar, M. A., Budán, F., & Csupor, D. (2024). Anticancer effects of secoiridoids—A scoping review of the molecular mechanisms behind the chemopreventive effects of the olive tree components oleocanthal, oleacein, and oleuropein. Nutrients, 16(16), 2755.
  • Érszegi, A., Viola, R., Bahar, M. A., Tóth, B., Fejes, I., Vágvölgyi, A., & Csupor, D. (2024). Not first‐line antihypertensive agents, but still effective—The efficacy and safety of imidazoline receptor agonists: A network meta‐analysis. Pharmacology Research & Perspectives, 12(3), e1215.
  • Pradipta, I. S., Khairunnisa, K., Bahar, M. A., Kausar, M. N., Fitriana, E., Ruslami, R., ... & Halimah, E. (2024). Characteristics, knowledge, attitude, and practice of pharmacy personnel in supporting tuberculosis treatment: A multicenter cross-sectional study in a high-burden tuberculosis country. Journal of the American Pharmacists Association, 64(3), 102077.
  • Saifudin, A., Bahar, M. A., Hidayatullah, M. H., Norimoto, H., Tezuka, Y., & Tanaka, K. (2024). Rethinking the basic action modes of herbal medicine and pondering classical standardization. Journal of Herbmed Pharmacology, 13(2), 163-175.
  • Kaaffah, S., Kusuma, I. Y., Renaldi, F. S., Lestari, Y. E., Pratiwi, A. D. E., & Bahar, M. A. (2023). Knowledge, attitudes, and perceptions of tuberculosis in Indonesia: a multi-center cross-sectional study. Infection and Drug Resistance, 1787-1800.
  • Kusuma, I. Y., Eka Pitaloka, D. A., Arbi, N. D., Sunarti, S., Pratiwi, H., Ali Omer, A. A., & Bahar, M. A. (2023). Five years of antibiotic consumption for urinary tract infection patients in Indonesia’s Provincial Public Hospital. Pharmacia (0428-0296), 70(3).
  • Kausar, M. N., Fitriana, E., Khairunnisa, K., Faruque, M. O., Bahar, M. A., Alfian, S. D., & Pradipta, I. S. (2023). Development and validation of the knowledge, attitude, and practice questionnaire for community pharmacy personnel in tuberculosis case detection, drug monitoring, and education: a study from Indonesia. Infection and Drug Resistance, 3729-3741.
  • Kusuma, I. Y., Matuz, M., Bordás, R., Juhasz Haverinen, M., Bahar, M. A., Hajdu, E., ... & Benko, R. (2022). Antibiotic use in elderly patients in ambulatory care: A comparison between Hungary and Sweden. Frontiers in Pharmacology, 13, 1042418.
  • Kusuma, I. Y., Matuz, M., Bordás, R., Juhasz Haverinen, M., Bahar, M. A., Hajdu, E., ... & Benko, R. (2022). Antibiotic use in elderly patients in ambulatory care: A comparison between Hungary and Sweden. Frontiers in Pharmacology, 13, 1042418.
  • Pradipta, I. S., Khairunnisa, K., Bahar, M. A., Kausar, M. N., Fitriana, E., Ruslami, R., ... & Abdulah, R. (2022). Knowledge, attitude and practice of community pharmacy personnel in tuberculosis patient detection: a multicentre cross-sectional study in a high-burden tuberculosis setting. BMJ open, 12(7), e060078.
Penghargaan / Hibah Relevan
  • Hibah Thematic Research Group Universitas Hasanuddin 2025. “Pengobatan Komplementer-Alternatif dan Faktor Psikososial pada Pasien Diabetes Melitus: Bukti Empiris untuk Mendukung Asta Cita Kesehatan dan Penguatan Obat Tradisional“. Role: PI. Amount: $ 3,600.
  • Riset Kolaborasi Indonesia (RKI) 2025. “Analisis Farmakoekonomi Dampak Pergantian Regimen Terapi Terhadap Kualitas Hidup Pasien HIV Pada Penggunaan Antiretroviral Dolutegravir’. Role: co-host. Amount: : $ 15,000.
  • Pharmacoeconomy Study on FSMP for stunting in Indonesia (2023-2024) funded by PT Sarihusada Generasi Mahardhika. Role: PI. Amount: $ 10,000.
  • Penelitian Fundamental Kolaboratif 2024. “Eksplorasi Penggunaan Drosophila Mutan dan Transgenik Sebagai High-Throughput In Vivo Pharmacological Model Dalam Upaya Meningkatkan Kapasitas Riset Drug Repurposing”. Role: member. Amount: $ 4,000.
  • Penelitian Dasar Unggulan Perguruan Tinggi (2021-2022), the Ministry of Education and Culture. “Skrining dan Evaluasi Kandidat Imunomodulator Menggunakan Model In Vivo Alternatif Drosophila Melanogaster Dalam Upaya Drug Repurposing”. Role: Member. Amount: $ 10,000.
  • RISBIN IPTEKDOK (2015), the Ministry of Health, Indonesia. “Progresifitas pembentukan abses, dermatonekrosis dan infiltrasi neutrofil pada S. aureus MDR skin and soft tissue infection (SSTI) model setelah pemberian gel etosom senyawa bioaktif fungi endofit Cabai Katokkon (Capsicum annuum L. Var. Chinensis)”. Role: PI. Amount: $ 10,000.
  • BOPTN (2014), the Ministry of Research, Technology and Higher Education, Indonesia. “‘Potensi bioselulosa yang difortifikasi dengan antimikroba alami sebagai pembalut luka bakar’. Role: Member. Amount: $ 5000.
  • Top 5% Finalist for the ISPOR (International Society for Pharmacoeconomics and Outcomes Research) Europe 2024 Research Presentation Awards
  • Best oral presenter, Pekan Ilmiah Tahunan (PIT) Ikatan Apoteker Indonesia (IAI) 2024
  • Best Scientific Article 2020 in the Field of Health and Medication from the Ministry of Research and Technology/National Agency for Research and Innovation, Indonesia. (2020)
  • Best oral presenter at the 3rd Makassar International Symposium on Pharmaceutical Sciences (MIPS), (2017)
  • The best graduate in the Bachelor's program in the Faculty of Mathematics and Natural Sciences, Universitas Hasanuddin. (2007)

Rumpun Kepakaran

Farmakologi

Kepakaran
  • Farmakologi
  • Farmakoepidemiologi

Jenis URL/Akun URL/Akun
LinkedIn https://id.linkedin.com/in/muh-akbar-bahar-60552644
Research Gate https://www.researchgate.net/profile/Muh-
Facebook https://www.facebook.com/muh.akbar.bahar/
Twitter https://x.com/kbarbahar
Instagram https://www.instagram.com/akbarbahar/
Skip to content